• 7029 malaria professionals are enjoying the free benefits of MalariaWorld today

traveller

Open Access | Rare disease: PCR negative cerebral malaria in a traveller returning from Mumbai

Author(s): 
Rohan Bhome, Rahul Bhome
Reference: 
BMJ Case Reports 2011
Contact email: 
rohan.bhome@ucl.ac.uk

The authors report a case of a healthy young man diagnosed with PCR negative cerebral malaria, a week after returning from Mumbai.

Open Access | Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malaria

Author(s): 
Rene te Witt R, van Wolfswinkel ME, Petit PL, van Hellemond JJ, Koelewijn R, van Belkum A, van Genderen PJ
Reference: 
Malaria Journal 2010, 9:255 (14 September 2010)
Contact email: 
r.tewitt@erasmusmc.nl

Although the diagnostic value of neopterin and procalcitonin is limited, the high negative predictive value of both neopterin and procalcitonin may be helpful for a rapid exclusion of severe malaria disease on admission.

Correspondence: Response to “letter to the editor” submitted by Dr Martin Tepper and Dr Steven Schofield – Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: Retrospective observational data. Travel Medici

Author(s): 
Jane N. Zuckerman, Anthony J. Batty, Michael E. Jones
Reference: 
Travel Medicine and Infectious Disease, Volume 8, Issue 3, May 2010, Pages 195-196
Contact email: 
j.zuckerman@medsch.ucl.ac.uk

 
 

Open Access | Research: Determining utility values related to malaria and malaria chemoprophylaxis

Author(s): 
McCarthy AE, Coyle D
Reference: 
Malaria Journal 2010, 9:92 (9 April 2010)

The general public (potential travellers), were more tolerant of taking prophylaxis if associated with no or mild AEs and least tolerant of mild sequelae from malaria and severe drug related events. The rating value reported for taking no prophylaxis was quite variable.

Systematic review: Low-quality evidence that atovaquone-proguanil and doxycycline are better tolerated prophylactic antimalarial regimens in travellers than mefloquine

Author(s): 
Michael Hawkes
Reference: 
Evid. Based Nurs. 2010; 13:19-20
Contact email: 
Michael.hawkes@utoronto.ca

he scope of this review is the prevention of Plasmodium falciparum, which is the malaria species that causes the overwhelming majority of severe disease and death, and which in many areas of the world is frequently resistant to the classical antimalarial agent chloroquine.

Malaria prevention behaviour and risk awareness in French adult travellers

Author(s): 
Thierry Pistone, Khaled Ezzedine, Anne-Françoise Gaudin, Serge Hercberg, Gaëlle Nachbaur, Denis Malvy
Reference: 
Travel Medicine and Infectious Disease, Volume 8, Issue 1, January 2010, Pages 13-21

The objective of this study was to assess malaria protection measures in European travellers as a function of the risk of infection with malaria. 

Systematic review: Cochrane Review highlights the need for more targeted research on the tolerability of malaria chemoprophylaxis in travellers

Author(s): 
Patricia Schlagenhauf
Reference: 
Evid Based Med 2010;15:25-26
Contact email: 
pat@ifspm.uzh.ch

Commentary on:
Jacquerioz FA, Croft AM . Drugs for preventing malaria in travellers. Cochrane Database Syst Rev 2009:CD006491.

Open Access | Modeling the risk of malaria for travellers to areas with stable malaria transmission

Author(s): 
Eduardo Massad, Ronald H Behrens, Marcelo N Burattini, Francisco AB Coutinho
Reference: 
Malaria Journal 2009, 8:296 (16 December 2009)
Contact email: 
edmassad@dim.fm.usp.br

Risk estimates based on mathematical modeling based on accurate data can be a valuable tool in assessing risk/benefits and cost/benefits when deciding on the value of interventions for travellers to malaria endemic regions.

Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: Retrospective observational data

Author(s): 
Jane N. Zuckerman, Anthony J. Batty, Michael E. Jones.
Reference: 
Travel Medicine and Infectious Disease, Volume 7, Issue 6, November 2009, Pages 329-336, doi:10.1016/j.tmaid.2009.10.002.

Further work is required to ascertain whether ease of use and compliance may be important factors in the outcomes associated with malariachemoprophylaxis.

Syndicate content